IP Verse

Arbutus Biopharma vs. Moderna - UPC_CFI_191/2025

The case UPC_CFI_191/2025 was filed by the plaintiff Arbutus Biopharma, Genevant Sciences against the defendant Moderna Netherlands on 03 Mar, 2025.

Case Timeline

03 Mar, 2025
Case Filed
09 Jul, 2025
Counterclaim for Revocation
24 Sep, 2025
Reply Filed
24 Sep, 2025
Rejoinder
24 Sep, 2025
Interim Conference
Today Nov 1, 2025
Oral Procedure
Decision

Case Details

    Case Number:

    UPC_CFI_191/2025

    Patent Number:

    EP2279254

    Filing Date:

    03 Mar, 2025

    Proceeding Type:

    Infringement

    Case Phase:

    Written Phase

    Plaintiffs:

    • Arbutus Biopharma
    • Genevant Sciences

    Plaintiff Representative:

    • Mark VAN GARDINGEN

    Defendants:

    • Moderna Netherlands

    Defendant Representative:

    • Ruben LADDÉ

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Samuel Granata
    • Xavier Dorland-Galliot

    Court Division:

    First Instance, Local Division - The Hague

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Oct 3, 2025Receipt
Oct 3, 2025Exhibit
Oct 3, 2025Cover Sheet
Oct 3, 2025Application
Sep 24, 2025Statement Of Reply
Sep 24, 2025Receipt
Sep 24, 2025Exhibit
Sep 24, 2025Cover Sheet
Sep 14, 2025Rejoinder On Request To Produce Evidence
Sep 12, 2025Uploaded For Technical Reasons Only To Close Workflow
Sep 12, 2025Upc Genevant Arbutus Reply R 190 Request Signed
Sep 12, 2025Outcome Of The Order
Sep 12, 2025Opportunity To Comment
Sep 2, 2025Receipt
Sep 2, 2025Moderna R.9 Rop In Response To R.190 Rop Application
Aug 28, 2025Receipt
Aug 27, 202525 08 27 Ep 254 Further Comment On Request To Produce Evidence Moderna Vs Genevant
Aug 26, 2025Reply Re R190 Request
Aug 26, 2025Exhibit G126
Aug 18, 2025Panel Appointment
Aug 18, 2025Opportunity To Comment
Aug 15, 2025R.37.2 Order
Aug 14, 2025Response To Request To Produce Evidence (Rule 190 Rop)
Aug 14, 2025Exhibit Fs18 DI 457 Letter May
Aug 14, 2025Exhibit Fs17 Protective Order
Aug 13, 2025Joint Statement Regarding Bifurcation
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop
Aug 8, 2025Response To Deadline Extension Request
Aug 6, 2025R.37
Aug 6, 2025R
Aug 6, 2025Hearing Dates
Aug 5, 2025Redacted Final Order Re R.262A Applications
Aug 4, 2025R.262A Order
Aug 4, 2025Outcome Of The Order
Aug 4, 2025Opportunity To Comment
Aug 1, 2025Request For Extension Of Deadlines
Aug 1, 2025Receipt
Aug 1, 2025Exhibit G125
Aug 1, 2025Exhibit G124
Aug 1, 2025Exhibit G123
Aug 1, 2025Application For An Order To Produce Evidence
Jul 28, 2025R.262A Reply
Jul 28, 2025Exhibit G122
Jul 25, 2025Receipt
Jul 24, 2025R.262A Reply
Jul 24, 2025Exhibit G122
Jul 23, 2025Reference To Response Of Genevant
Jul 23, 2025R.262.2 Application
Jul 23, 2025Exhibit G121 Confidential
Jul 23, 2025Exhibit G120
Jul 23, 2025Exhibit G119
Jul 23, 2025Confidential Response To Security
Jul 11, 2025Formal Checks Notification Of Positive Outcome
Jul 11, 2025Acknowledgement Of Lodging
Jul 10, 2025Set Of Exhibits Fbd T 09 Confidential
Jul 10, 2025Set Of Exhibits Fbd 11
Jul 10, 2025Set Of Exhibits Fbd 10 Part 5 Of 5
Jul 10, 2025Set Of Exhibits Fbd 10 Part 4 Of 5
Jul 10, 2025Set Of Exhibits Fbd 10 Part 3 Of 5
Jul 10, 2025Set Of Exhibits Fbd 10 Part 2 Of 5
Jul 10, 2025Set Of Exhibits Fbd 10 Part 1 Of 5
Jul 10, 2025Opportunity To Comment
Jul 10, 2025Formal Checks Request For Correction
Jul 10, 2025Exhibit Fbd T 19
Jul 10, 2025Exhibit Fbd T 18
Jul 10, 2025Exhibit Fbd T 17
Jul 10, 2025Exhibit Fbd T 16
Jul 10, 2025Exhibit Fbd T 15
Jul 10, 2025Exhibit Fbd T 14
Jul 10, 2025Exhibit Fbd T 13
Jul 10, 2025Exhibit Fbd T 12
Jul 10, 2025Exhibit Fbd T 11
Jul 10, 2025Exhibit Fbd T 10
Jul 10, 2025Exhibit Fbd T 09A Confidential
Jul 10, 2025Exhibit Fbd T 08
Jul 10, 2025Exhibit Fbd T 07
Jul 10, 2025Exhibit Fbd T 06
Jul 10, 2025Exhibit Fbd T 05
Jul 10, 2025Exhibit Fbd T 04
Jul 10, 2025Exhibit Fbd T 03A
Jul 10, 2025Exhibit Fbd T 03
Jul 10, 2025Exhibit Fbd T 02
Jul 10, 2025Exhibit Fbd T 01
Jul 10, 2025Exhibit Fbd 16
Jul 10, 2025Exhibit Fbd 15
Jul 10, 2025Exhibit Fbd 14
Jul 10, 2025Exhibit Fbd 13
Jul 10, 2025Exhibit Fbd 12 Confidential
Jul 10, 2025Exhibit Fbd 11A
Jul 10, 2025Exhibit Fbd 09
Jul 10, 2025Exhibit Fbd 08
Jul 10, 2025Exhibit Fbd 07
Jul 10, 2025Exhibit Fbd 06
Jul 10, 2025Annex 7 To Exhibit Fbd T 4
Jul 10, 2025Annex 6 To Exhibit Fbd T 4
Jul 10, 2025Annex 5 To Exhibit Fbd T 4
Jul 10, 2025Annex 4 To Exhibit Fbd T 4
Jul 10, 2025Annex 3 To Exhibit Fbd T 4
Jul 10, 2025Annex 2 To Exhibit Fbd T 4
Jul 10, 2025Annex 1 To Exhibit Fbd T 4
Jul 10, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025 V2
Jul 9, 2025Set Of Exhibits Fbd T 09 Confidential
Jul 9, 2025Set Of Exhibits Fbd 11
Jul 9, 2025Set Of Exhibits Fbd 10 Part 5 Of 5
Jul 9, 2025Set Of Exhibits Fbd 10 Part 4 Of 5
Jul 9, 2025Set Of Exhibits Fbd 10 Part 3 Of 5
Jul 9, 2025Set Of Exhibits Fbd 10 Part 2 Of 5
Jul 9, 2025Set Of Exhibits Fbd 10 Part 1 Of 5
Jul 9, 2025Receipt
Jul 9, 2025Opportunity To Comment
Jul 9, 2025Exhibit Fbd T 19
Jul 9, 2025Exhibit Fbd T 18
Jul 9, 2025Exhibit Fbd T 17
Jul 9, 2025Exhibit Fbd T 16
Jul 9, 2025Exhibit Fbd T 15
Jul 9, 2025Exhibit Fbd T 14
Jul 9, 2025Exhibit Fbd T 13
Jul 9, 2025Exhibit Fbd T 12
Jul 9, 2025Exhibit Fbd T 11
Jul 9, 2025Exhibit Fbd T 10
Jul 9, 2025Exhibit Fbd T 09A Confidential
Jul 9, 2025Exhibit Fbd T 08
Jul 9, 2025Exhibit Fbd T 07
Jul 9, 2025Exhibit Fbd T 06
Jul 9, 2025Exhibit Fbd T 05
Jul 9, 2025Exhibit Fbd T 04
Jul 9, 2025Exhibit Fbd T 03A
Jul 9, 2025Exhibit Fbd T 03
Jul 9, 2025Exhibit Fbd T 02
Jul 9, 2025Exhibit Fbd T 01
Jul 9, 2025Exhibit Fbd 16
Jul 9, 2025Exhibit Fbd 15
Jul 9, 2025Exhibit Fbd 14
Jul 9, 2025Exhibit Fbd 13
Jul 9, 2025Exhibit Fbd 12 Confidential
Jul 9, 2025Exhibit Fbd 11A
Jul 9, 2025Exhibit Fbd 09
Jul 9, 2025Exhibit Fbd 08
Jul 9, 2025Exhibit Fbd 07
Jul 9, 2025Exhibit Fbd 06
Jul 9, 2025EP254 Moderna Reference To Statement Of Defence And Counterclaim For Revocation
Jul 9, 2025Annex 7 To Exhibit Fbd T 4
Jul 9, 2025Annex 6 To Exhibit Fbd T 4
Jul 9, 2025Annex 5 To Exhibit Fbd T 4
Jul 9, 2025Annex 4 To Exhibit Fbd T 4
Jul 9, 2025Annex 3 To Exhibit Fbd T 4
Jul 9, 2025Annex 2 To Exhibit Fbd T 4
Jul 9, 2025Annex 1 To Exhibit Fbd T 4
Jul 9, 2025Acknowledgement Of Lodging
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Request Security Pursuant To R158 No 32591 2025
Jul 9, 202525 07 08 Upc2 EP254 Upc Draft Confidentiality Request
Jul 9, 202507 08 Upc1 EP254 Reference To Statement Of Defence For Other Defendants(307430487.1)
Jul 9, 202507 08 EP254 Moderna Vs Genevant Statement Of Defence Act 10280 2025 Ccr 32137 2025
Jun 19, 2025Response To Request For Review
Jun 12, 2025Outcome Of The Order
Jun 12, 2025Opportunity To Comment
Jun 11, 2025Acknowledgement Of Lodging
Jun 6, 2025Exhibit Fbd 5
Jun 6, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 27016 2025
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order
Jun 4, 2025Headnote And Keywords
Jun 2, 2025Response To Request For Rectification
May 28, 2025Opportunity To Comment
May 27, 2025Receipt
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome
May 7, 2025Exhibit G118 Notice European Tender
May 7, 2025Exhibit G117 Certificate Amalgamation
May 7, 2025Exhibit G116 Opt Out Confirmation
May 7, 2025Exhibit G115 Opt Out
May 7, 2025Comment On Preliminary Objection
May 7, 2025Comment On Preliminary Objection
May 6, 2025Notification Of Service
May 6, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Norway As
May 5, 2025Acknowledgement Of Access To Case
May 1, 2025Notification Of Service
May 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Switzerland Gmbh
Apr 25, 2025Preliminary Objection
Apr 25, 2025Notification Of Service
Apr 25, 2025Exhibit Fbd 4 Moderna Pl
Apr 25, 2025Exhibit Fbd 3 Dutch Patent Register
Apr 25, 2025Exhibit Fbd 2 National Registers
Apr 25, 2025Act 10280 Upc Cfi 191 Confirmation Of Service
Apr 25, 202525 04 24 EP254 Preliminary Objection Moderna VS Genevant Signed
Apr 23, 2025Preliminary Objection
Apr 22, 2025Preliminary Objection Moderna Uk Moderna VS Genevant (EP254) Signed
Apr 22, 2025Notification Of Service
Apr 22, 2025Exhibit Fbd 3 Dutch Patent Register
Apr 22, 2025Exhibit Fbd 2 National Registers
Apr 22, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Inc.
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Response To Letter Brinkhof D.D17 April
Apr 17, 2025Receipt
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc
Apr 17, 2025Outcome Of The Order
Apr 17, 2025Headnote And Keywords
Apr 17, 2025Exhibit G114 Letter Re Representation Mll Of Moderna Inc Modernatx Inc
Apr 15, 2025Receipt
Apr 15, 2025Notification Of Service
Apr 15, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Sweden Ab
Apr 15, 202525 04 15 EP254 Response Re Deadline Extension
Apr 14, 2025Receipt
Apr 14, 2025R 9 Aplication Reply To R 9 Request
Apr 10, 2025Template Order
Apr 10, 2025Opportunity To Comment
Apr 9, 2025Receipt
Apr 9, 2025Opportunity To Comment
Apr 9, 2025Exhibit Fbd 1
Apr 9, 202525 04 09 EP254 Request For Deadline Extension Moderna VS Genevant Arbutus Cfi 191 2025 Act 10280 2025
Apr 1, 2025Notification Of Service
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Netherlands B.V.
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Italy S.R.L.
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Germany Gmbh
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna France Sasu
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Denmark Aps
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Uk Limited
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Biotech Spain Sl
Apr 1, 2025Act 10280 2025 Upc Cfi 191 2025 Confirmation Of Service Moderna Belgium S.R.L.
Mar 31, 2025Acknowledgement Of Access To Case
Mar 28, 2025Acknowledgement Of Access To Case
Mar 24, 2025Acknowledgement Of Access To Case
Mar 17, 2025Panel Appointment
Mar 13, 2025Letter For Service
Mar 11, 2025Document From Epo
Mar 6, 2025Receipt
Mar 6, 2025Panel Appointment
Mar 6, 2025Formal Checks Notification Of Positive Outcome
Mar 6, 2025Epo Request For Case Pending
Mar 5, 2025Statement Of Claim EP254 Signed
Mar 5, 2025Statement Of Claim EP254Da
Mar 5, 2025Raw Data Uv
Mar 5, 2025Raw Data Lc Cad Sample C3
Mar 5, 2025Raw Data Lc Cad Sample C2
Mar 5, 2025Raw Data Lc Cad Sample C1
Mar 5, 2025Raw Data Dls
Mar 5, 2025Exhibit M.04 United States Pharmacopeia
Mar 5, 2025Exhibit M.03 Semple
Mar 5, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture
Mar 5, 2025Exhibit M.01 Samaridou
Mar 5, 2025Exhibit G113 Moderna Inc Annual Report Selection
Mar 5, 2025Exhibit G112 Moderna Annual Report P. 119
Mar 5, 2025Exhibit G111 Moderna Recipharm Press Release
Mar 5, 2025Exhibit G110 Moderna Recipharm Press Release
Mar 5, 2025Exhibit G109 Moderna Rovi Press Release
Mar 5, 2025Exhibit G108 Moderna Rovi Press Release
Mar 5, 2025Exhibit G107 Lonza Press Release
Mar 5, 2025Exhibit G106 Moderna Press Release Lonza Nl
Mar 5, 2025Exhibit G105 Moderna Ch Service Agreement Tr
Mar 5, 2025Exhibit G104 Moderna Lonza Press Release
Mar 5, 2025Exhibit G103 Moderna Portugal Trade Register
Mar 5, 2025Exhibit G102 Moderna Norway Trade Register
Mar 5, 2025Exhibit G101 Moderna Sweden Trade Register
Mar 5, 2025Exhibit G100 Moderna Denmark Trade Register
Mar 5, 2025Exhibit G099 Moderna Belgium Trade Register
Mar 5, 2025Exhibit G098 Moderna Italy Trade Register
Mar 5, 2025Exhibit G097 Moderna France Trade Register
Mar 5, 2025Exhibit G096 Moderna Germany Trade Register
Mar 5, 2025Exhibit G095 Moderna Uk Annual Report
Mar 5, 2025Exhibit G094 Moderna Uk Trade Register
Mar 5, 2025Exhibit G093 Moderna Poland Trade Register
Mar 5, 2025Exhibit G092 Moderna Netherlands Madrid
Mar 5, 2025Exhibit G091 Moderna Es Trade Register
Mar 5, 2025Exhibit G090 Mresvia Lauer Taxe Germany
Mar 5, 2025Exhibit G089 Spikevax Lauer Taxe Germany
Mar 5, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl
Mar 5, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl
Mar 5, 2025Exhibit G086 Moderna Nl Hungary Contract
Mar 5, 2025Exhibit G085 Moderna Nl Hungary Contract Hun
Mar 5, 2025Exhibit G084 Moderna Nl Annual Report
Mar 5, 2025Exhibit G083 Moderna Nl Trade Register
Mar 5, 2025Exhibit G082 Ec Draft Framework Contract
Mar 5, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser
Mar 5, 2025Exhibit G080 Moderna Press Release Tender
Mar 5, 2025Exhibit G079 Ec Press Release Tender
Mar 5, 2025Exhibit G078 Ex Pa Ec Moderna Ch
Mar 5, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61
Mar 5, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60
Mar 5, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53
Mar 5, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44
Mar 5, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35
Mar 5, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26
Mar 5, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17
Mar 5, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8
Mar 5, 2025Exhibit G076 Moderna Switzerland Trade Register
Mar 5, 2025Exhibit G075 Modernacovid19Global Website
Mar 5, 2025Exhibit G074 Modernatx Website
Mar 5, 2025Exhibit G073 Domain Registrations Moderna
Mar 5, 2025Exhibit G072 Modernatx Trade Register Excerpt
Mar 5, 2025Exhibit G071 Moderna Inc Press Release
Mar 5, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1
Mar 5, 2025Exhibit G069 Moderna Inc Trade Register Excerpt
Mar 5, 2025Exhibit G068 Coriolis Report
Mar 5, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection
Mar 5, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92
Mar 5, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection
Mar 5, 2025Exhibit G064 Ema Assesment Report Mresvia
Mar 5, 2025Exhibit G063 Moderna Press Release 23 August
Mar 5, 2025Exhibit G062 Mresvia Smpc
Mar 5, 2025Exhibit G061 Mitchell Report Table Of Content
Mar 5, 2025Exhibit G060 Coriolis Report Table Of Content
Mar 5, 2025Exhibit G059 WO2022197624A1
Mar 5, 2025Exhibit G058 WO2021222304A1
Mar 5, 2025Exhibit G057 WO2021159130A2
Mar 5, 2025Exhibit G056 Richner
Mar 5, 2025Exhibit G055 Bahl
Mar 5, 2025Exhibit G054 Espeseth
Mar 5, 2025Exhibit G053 John
Mar 5, 2025Exhibit G052 Peer Review Corbett Nature
Mar 5, 2025Exhibit G051 Hassett
Mar 5, 2025Exhibit G050 Ema Assessment Report Spikevax
Mar 5, 2025Exhibit G049 Epo Ar1 To Ar13
Mar 5, 2025Exhibit G048 Ar13 Redlined
Mar 5, 2025Exhibit G047 Mr Redlined
Mar 5, 2025Exhibit G046 Mitchell Report
Mar 5, 2025Exhibit G045 Petitioners Hearing Slides Slide 27
Mar 5, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73
Mar 5, 2025Exhibit G043 D44 Declaration Heyes
Mar 5, 2025Exhibit G042 D43 Declaration Heyes
Mar 5, 2025Exhibit G041 Modernas Goa Of 22 November
Mar 5, 2025Exhibit G040 Arbutuss Goa Of 25 November
Mar 5, 2025Exhibit G039 Main Request
Mar 5, 2025Exhibit G038 US2006 0240554 (D25)
Mar 5, 2025Exhibit G037 Auxiliary Request 13
Mar 5, 2025Exhibit G036 Od Decision
Mar 5, 2025Exhibit G035 T 0505 20
Mar 5, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October
Mar 5, 2025Exhibit G033 Od Decision
Mar 5, 2025Exhibit G032 US20080020058(Chen)
Mar 5, 2025Exhibit G031 Amended Claim With Annotations 13 September
Mar 5, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May
Mar 5, 2025Exhibit G029 Extended European Search Report 12 October
Mar 5, 2025Exhibit G028 Amendments Received Before Examination 30 December
Mar 5, 2025Exhibit G027 Withdrawal Of The Op Out
Mar 5, 2025Exhibit G026 US20080045228P Priority Document
Mar 5, 2025Exhibit G025 WO2009127060A1 Original Application
Mar 5, 2025Exhibit G024 Samaridou
Mar 5, 2025Exhibit G023 Genevant Press Release
Mar 5, 2025Exhibit G022 Federal Circuit Opinion (435)
Mar 5, 2025Exhibit G021 Federal Circuit Opinion (069)
Mar 5, 2025Exhibit G020 Ipr Final Written Decision (435)
Mar 5, 2025Exhibit G019 Ipr Final Written Decision (069)
Mar 5, 2025Exhibit G018 US9364435
Mar 5, 2025Exhibit G017 US8058069
Mar 5, 2025Exhibit G016 Moore Harvard Business School
Mar 5, 2025Exhibit G015 Moderna Nih Preprint
Mar 5, 2025Exhibit G014 CR OSS Cen News
Mar 5, 2025Exhibit G013 Regalado Mit Technology
Mar 5, 2025Exhibit G012 Corbett Nature Review
Mar 5, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration
Mar 5, 2025Exhibit G010 Suzuki
Mar 5, 2025Exhibit G009 Semple
Mar 5, 2025Exhibit G008 Zimmerman
Mar 5, 2025Exhibit G007 Spikevax Smpc
Mar 5, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt
Mar 5, 2025Exhibit G005 Genevant Sciences Trade Register
Mar 5, 2025Exhibit G004 Proof Of Payment Court Fees
Mar 5, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus
Mar 5, 2025Exhibit G002 Patent Register Excerpts
Mar 5, 2025Exhibit G001 EP2279254B1
Mar 5, 2025Exhibit C Qualification Report
Mar 5, 2025Exhibit B Cv Katharina Edenharter
Mar 5, 2025Exhibit A Cv Thomas Lassak
Mar 4, 2025Formal Checks Request For Correction
Mar 3, 2025Statement Of Claim EP254 Signed
Mar 3, 2025Raw Data Uv
Mar 3, 2025Raw Data Lc Cad Sample C3
Mar 3, 2025Raw Data Lc Cad Sample C2
Mar 3, 2025Raw Data Lc Cad Sample C1
Mar 3, 2025Raw Data Dls
Mar 3, 2025Exhibit M.04 United States Pharmacopeia
Mar 3, 2025Exhibit M.03 Semple
Mar 3, 2025Exhibit M.02 Katalin Kariko, Keynote Lecture
Mar 3, 2025Exhibit M.01 Samaridou
Mar 3, 2025Exhibit G113 Moderna Inc Annual Report Selection
Mar 3, 2025Exhibit G112 Moderna Annual Report P. 119
Mar 3, 2025Exhibit G111 Moderna Recipharm Press Release
Mar 3, 2025Exhibit G110 Moderna Recipharm Press Release
Mar 3, 2025Exhibit G109 Moderna Rovi Press Release
Mar 3, 2025Exhibit G108 Moderna Rovi Press Release
Mar 3, 2025Exhibit G107 Lonza Press Release
Mar 3, 2025Exhibit G106 Moderna Press Release Lonza Nl
Mar 3, 2025Exhibit G105 Moderna Ch Service Agreement Tr
Mar 3, 2025Exhibit G104 Moderna Lonza Press Release
Mar 3, 2025Exhibit G103 Moderna Portugal Trade Register
Mar 3, 2025Exhibit G102 Moderna Norway Trade Register
Mar 3, 2025Exhibit G101 Moderna Sweden Trade Register
Mar 3, 2025Exhibit G100 Moderna Denmark Trade Register
Mar 3, 2025Exhibit G099 Moderna Belgium Trade Register
Mar 3, 2025Exhibit G098 Moderna Italy Trade Register
Mar 3, 2025Exhibit G097 Moderna France Trade Register
Mar 3, 2025Exhibit G096 Moderna Germany Trade Register
Mar 3, 2025Exhibit G095 Moderna Uk Annual Report
Mar 3, 2025Exhibit G094 Moderna Uk Trade Register
Mar 3, 2025Exhibit G093 Moderna Poland Trade Register
Mar 3, 2025Exhibit G092 Moderna Netherlands Madrid
Mar 3, 2025Exhibit G091 Moderna Es Trade Register
Mar 3, 2025Exhibit G090 Mresvia Lauer Taxe Germany
Mar 3, 2025Exhibit G089 Spikevax Lauer Taxe Germany
Mar 3, 2025Exhibit G088 Moderna Nl Tender Notice Poland Pl
Mar 3, 2025Exhibit G087 Moderna Nl Pl Tender Notice Pl
Mar 3, 2025Exhibit G086 Moderna Nl Hungary Contract
Mar 3, 2025Exhibit G085 Moderna Nl Hungary Contract Hun
Mar 3, 2025Exhibit G084 Moderna Nl Annual Report
Mar 3, 2025Exhibit G083 Moderna Nl Trade Register
Mar 3, 2025Exhibit G082 Ec Draft Framework Contract
Mar 3, 2025Exhibit G081 Moderna Inc. Press Release Chantal Friebertshauser
Mar 3, 2025Exhibit G080 Moderna Press Release Tender
Mar 3, 2025Exhibit G079 Ec Press Release Tender
Mar 3, 2025Exhibit G078 Ex Pa Ec Moderna Ch
Mar 3, 2025Exhibit G077.8 Apa Ec Moderna Ch P 61
Mar 3, 2025Exhibit G077.7 Apa Ec Moderna Ch P 54 60
Mar 3, 2025Exhibit G077.6 Apa Ec Moderna Ch P 45 53
Mar 3, 2025Exhibit G077.5 Apa Ec Moderna Ch P 36 44
Mar 3, 2025Exhibit G077.4 Apa Ec Moderna Ch P 27 35
Mar 3, 2025Exhibit G077.3 Apa Ec Moderna Ch P 18 26
Mar 3, 2025Exhibit G077.2 Apa Ec Moderna Ch P 9 17
Mar 3, 2025Exhibit G077.1 Apa Ec Moderna Ch P 1 8
Mar 3, 2025Exhibit G076 Moderna Switzerland Trade Register
Mar 3, 2025Exhibit G075 Modernacovid19Global Website
Mar 3, 2025Exhibit G074 Modernatx Website
Mar 3, 2025Exhibit G073 Domain Registrations Moderna
Mar 3, 2025Exhibit G072 Modernatx Trade Register Excerpt
Mar 3, 2025Exhibit G071 Moderna Inc Press Release
Mar 3, 2025Exhibit G070 Moderna Inc Annual Report Exhibit 21 1
Mar 3, 2025Exhibit G069 Moderna Inc Trade Register Excerpt
Mar 3, 2025Exhibit G068 Coriolis Report
Mar 3, 2025Exhibit G067 Modernas Rd Day Transcript 17 September Selection
Mar 3, 2025Exhibit G066 Modernas Rd Day Presentation 17 September Slide 92
Mar 3, 2025Exhibit G065 Transcript Moderna Vaccines DAY 14 April Selection
Mar 3, 2025Exhibit G064 Ema Assesment Report Mresvia
Mar 3, 2025Exhibit G063 Moderna Press Release 23 August
Mar 3, 2025Exhibit G062 Mresvia Smpc
Mar 3, 2025Exhibit G061 Mitchell Report Table Of Content
Mar 3, 2025Exhibit G060 Coriolis Report Table Of Content
Mar 3, 2025Exhibit G059 WO2022197624A1
Mar 3, 2025Exhibit G058 WO2021222304A1
Mar 3, 2025Exhibit G057 WO2021159130A2
Mar 3, 2025Exhibit G056 Richner
Mar 3, 2025Exhibit G055 Bahl
Mar 3, 2025Exhibit G054 Espeseth
Mar 3, 2025Exhibit G053 John
Mar 3, 2025Exhibit G052 Peer Review Corbett Nature
Mar 3, 2025Exhibit G051 Hassett
Mar 3, 2025Exhibit G050 Ema Assessment Report Spikevax
Mar 3, 2025Exhibit G049 Epo Ar1 To Ar13
Mar 3, 2025Exhibit G048 Ar13 Redlined
Mar 3, 2025Exhibit G047 Mr Redlined
Mar 3, 2025Exhibit G046 Mitchell Report
Mar 3, 2025Exhibit G045 Petitioners Hearing Slides Slide 27
Mar 3, 2025Exhibit G044 Anchordoquy Deposition Transcript P. 70 73
Mar 3, 2025Exhibit G043 D44 Declaration Heyes
Mar 3, 2025Exhibit G042 D43 Declaration Heyes
Mar 3, 2025Exhibit G041 Modernas Goa Of 22 November
Mar 3, 2025Exhibit G040 Arbutuss Goa Of 25 November
Mar 3, 2025Exhibit G039 Main Request
Mar 3, 2025Exhibit G038 US2006 0240554 (D25)
Mar 3, 2025Exhibit G037 Auxiliary Request 13
Mar 3, 2025Exhibit G036 Od Decision
Mar 3, 2025Exhibit G035 T 0505 20
Mar 3, 2025Exhibit G034 Information About The Result Of Oral Proceedings Of 10 October
Mar 3, 2025Exhibit G033 Od Decision
Mar 3, 2025Exhibit G032 US20080020058(Chen)
Mar 3, 2025Exhibit G031 Amended Claim With Annotations 13 September
Mar 3, 2025Exhibit G030 Amended Claims Filed After Receipt Of Search Report 7 May
Mar 3, 2025Exhibit G029 Extended European Search Report 12 October
Mar 3, 2025Exhibit G028 Amendments Received Before Examination 30 December
Mar 3, 2025Exhibit G027 Withdrawal Of The Op Out
Mar 3, 2025Exhibit G026 US20080045228P Priority Document
Mar 3, 2025Exhibit G025 WO2009127060A1 Original Application
Mar 3, 2025Exhibit G024 Samaridou
Mar 3, 2025Exhibit G023 Genevant Press Release
Mar 3, 2025Exhibit G022 Federal Circuit Opinion (435)
Mar 3, 2025Exhibit G021 Federal Circuit Opinion (069)
Mar 3, 2025Exhibit G020 Ipr Final Written Decision (435)
Mar 3, 2025Exhibit G019 Ipr Final Written Decision (069)
Mar 3, 2025Exhibit G018 US9364435
Mar 3, 2025Exhibit G017 US8058069
Mar 3, 2025Exhibit G016 Moore Harvard Business School
Mar 3, 2025Exhibit G015 Moderna Nih Preprint
Mar 3, 2025Exhibit G014 CR OSS Cen News
Mar 3, 2025Exhibit G013 Regalado Mit Technology
Mar 3, 2025Exhibit G012 Corbett Nature Review
Mar 3, 2025Exhibit G011 Shaun Ryan (Moderna) Declaration
Mar 3, 2025Exhibit G010 Suzuki
Mar 3, 2025Exhibit G009 Semple
Mar 3, 2025Exhibit G008 Zimmerman
Mar 3, 2025Exhibit G007 Spikevax Smpc
Mar 3, 2025Exhibit G006 Arbutus Biopharma Corporation Trade Register Excerpt
Mar 3, 2025Exhibit G005 Genevant Sciences Trade Register
Mar 3, 2025Exhibit G004 Proof Of Payment Court Fees
Mar 3, 2025Exhibit G003 Confirmatory Declaration Genevant Arbutus
Mar 3, 2025Exhibit G002 Patent Register Excerpts
Mar 3, 2025Exhibit G001 EP2279254B1
Mar 3, 2025Exhibit C Qualification Report
Mar 3, 2025Exhibit B Cv Katharina Edenharter
Mar 3, 2025Exhibit A Cv Thomas Lassak
Mar 3, 2025EP254Soc Da
Mar 3, 2025Acknowledgement Of Lodging

More cases involving EP2279254B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_617/2025Jul 9, 2025ModernaArbutus Biopharma
CC_32138/2025Jul 8, 2025ModernaArbutus Biopharma
ACT_10280/2025Mar 3, 2025Arbutus Biopharma, Genevant SciencesModerna

More cases involving Arbutus Biopharma

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus BiopharmaModerna
ORD_34391/2025Aug 6, 2025Arbutus BiopharmaModerna
APP_34202/2025Aug 1, 2025Arbutus Biopharma -

More cases involving Moderna

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
ORD_34391/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
APP_33094/2025Jul 17, 2025Moderna -